# A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

> **NCT06050226** · PHASE2 · COMPLETED · sponsor: **Wuhan Createrna Science and Technology Co., Ltd** · enrollment: 34 (actual)

## Conditions studied

- Paroxysmal Nocturnal Hemoglobinuria

## Interventions

- **DRUG:** MY008211A tablets

## Key facts

- **NCT ID:** NCT06050226
- **Lead sponsor:** Wuhan Createrna Science and Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-06
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-11-28
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06050226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06050226, "A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06050226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*